Search Results: sensitivity (17)

The industry is worried.

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek

President-elect Donald Trump nominated anti-pot hardliner Sen. Jeff Sessions of Alabama (R) for Attorney General. At a Senate hearing in April 2016, Sessions said that ‘we need grown-ups in charge in Washington to say marijuana is not the kind of thing that ought to be legalized, it ought not to be minimized, that it’s in fact a very real danger.’

“I think one of [Obama’s] great failures, it’s obvious to me, is his lax treatment in comments on marijuana,” Sessions said at the hearing. “It reverses 20 years almost of hostility to drugs that began really when Nancy Reagan started ‘Just Say No.’ ”

Lawmakers, he said, have to “send that message with clarity that good people don’t smoke marijuana.”
USNews calls Sessions an “ Existential threat” to state-legal cannabis. Industry leaders are very nervous.

Reason points out that Sessions has an “aversion to civil rights” and gay rights. The U.S. Senate failed to confirm him for a federal judgeship in 1986, amid allegations of what late Senator Ted Kennedy called “racial insensitivity” and “lack of commitment to equal justice under the law.” The New York Times editorializes that the nomination is an “ insult to justice.”

What does a Trump presidency mean for the industry? The transition team isn’t talking. NBC speculates.So does CBS.

The Sessions nomination needs to be approved by the Senate. Have a view you want to share?  Contact your Senator.

Before the Sessions pick, the Washington Post’s Radley Balko said former New York Mayor Rudy Giuliani (R) would also be “ terrifying.”

Before the Sessions pick, anti-legalization activist Kevin Sabet said, “A Trump administration throws everything up in the air… “Is it going to be ‘ states’ rights Trump’ or ‘law-and-order Trump’?”

Marijuana.com’s Tom Angell has launched a petition for Trump to keep his “marijuana pledge” to respect state laws.  Even if he doesn’t go after the industry, The Stranger says President Trump will  make the industry whiter.

It’s official, Denver will be the first U.S. city to license social use businesses.

After the Massachusetts REC vote, Rhode Island could legalize REC through the legislature. Alaska is setting up a  drop box system  to collect taxes in cash.

Tennessee Attorney General Herbert Slatery (R), said looser cannabis regulations in Memphis and Nashville can’t stand.

Due to a glitch, it appears that MED in California will be tax-free until the state’s REC program begins in 2018.

Some conservatives don’t like that MED patients can’t buy guns.

AlexK100/Flickr.


A Washington State University study shows that female mice are more susceptible to the pain-relieving qualities of cannabis than male mice, but that increased sensitivity means the female mice also developed a higher tolerance faster than the males.
The study could provide valuable insight into future testing of cannabis use, which has predominantly been done on men.

In a new study published this week in Nature Neuroscience, European researchers claim to have proven that smoking weed does, in fact, give you the munchies. Beyond that, they appear to have isolated the specific region of the brain that is affected by THC consumption, and identified the process through which that desire to eat an entire box of Lucky Charms at 2am comes from.

Flickr.com/enerva
So many choices…


In their study, the team of neuroscientists used a mischief of mice to conduct their herbal experimentation on, due to the cognitive similarities that mice share with humans. Roughly half the time, the mice got to get super baked, the other half they had to sit around sober as churchmice, and then…well…what happened to some of the poor critters near the end is downright freaky.

O’Dea/Wiki Commons

Americans for Safe Access will hold its first compulsory training course on February 1st
The medical marijuana advocacy group Americans for Safe Access (ASA) was awarded a permit by the D.C. Department of Health last week to implement its compulsory training for cultivators and distributors licensed by the District. ASA Foundation was selected to be the Medical Marijuana Certification Provider based on its longstanding experience providing such trainings across the country.

Crucify The Ego

Worth Repeating
By Ron Marczyk, R.N.
Health Education Teacher (Retired)
Ever notice that when people smoke marijuana they are frequently overcome with feelings of deep introspection and metacognition which often lead to lively discussions with overt existential themes?
Cannabinoids increase introspection, metacognition, emotional sentience, and entheogenic experiences.
Perhaps these effects are responsible for the sharp decrease seen in suicide rates of young men?
Perhaps medical marijuana makes life worth living!
This curious, and well known effect of marijuana’s overall euphoria “to bear well” is apparently caused by activating emotional sentience pathways in the amygdala — and that’s a good thing!

Cage Potato

Worth Repeating
​By Ron Marczyk, R.N.
Health Education Teacher (Retired)
The reductionist, “group think,” cold, dogmatic drug warriors of the National Institute of Drug Abuse, the DEA, and the FDA have been digesting their own misinformation for so long they have lost their humanity. 
As counterintuitive as it sounds, the” high” or “feel good” buzz from marijuana is an actual “therapeutic effect” that heals the brain, produces homeostasis and prevents many neurodegenerative conditions.
Brain homeostasis is restored by the direct action of THC/CBD-activating CB1 receptors in the amygdala which regulate our “happiness / emotional salience module.” This pathway is dedicated to seeking for “meaningfulness” in our existence.
This innate drive is the need for self-actualization. THC increases the probability of these events occurring, through inducing metaphysical “flow states” and “peak experiences.” 

Rialto Cinemas

​​By Jack Rikess
Toke of the Town
Northern California Correspondent
The Weed Wars are on, and at stake are television ratings. In the next couple of weeks we’ll start to see the bounty of this year’s harvest of cannabis-centric TV hitting the airwaves. 
The ever-present Steve DeAngelo has his reality series starting on the Discovery Channel a la Kiss’s Gene Simmons: depicting a world class guy with the weight of the world on his shoulders yet he has time to take his kid to Little League. Just a regular guy and family man who happens to like to bang the gong at the end of the day. America won’t believe their eyes.
This Friday the National Geographic Channel is joining the Cannafest with the premiere of Marijuana Gold Rush. Depicting the many highs and a few lows of this past year’s emerging dream of bringing cannabis into the mainstream, going from the boardrooms of New York to our own Mendocino County’s Emerald Cup, with the participants not knowing what really is to come.

Philly.com

​Scientists at Temple University in Philadelphia who are exploring the medical benefits of cannabidiol (CBD), a marijuana compound that does not produce the high associated with THC, have found that it’s effective in helping prevent neuropathic pain.

CBD, the second major cannabinoid in pot after THC, has anti-inflammatory and pain-relieving properties, but no psychoactive effects, according to the scientists, reports Tom Avril at Philly.com.
In a study using lab mice, CBD showed promise in preventing the kind of neuropathic pain that can result from the chemotherapy drug paclitaxel (sold as the brand-name Taxol, among others).
Mice that were given paclitaxel and also received CBD were much less sensitive to pain than mice that receive only chemo.

Photo: Geoff Pugh/The Telegraph
Ben Whalley, middle, with Dr Gary Stephens and Dr Claire Williams of Reading University at a secret cannabis farm in the south of England in the hope of producing a new treatment for epilepsy

​Welcome to Room 420, where your instructor is Mr. Ron Marczyk and your subjects are wellness, disease prevention, self actualization, and chillin’.

Worth Repeating

By Ron Marczyk, R.N.

An overwhelming amount of very promising research has been gathered supporting the use of medical cannabis for many illnesses and diseases… and the evidence is now impossible to ignore.

Examples:
“The endogenous cannabinoid system has revealed potential avenues to treat many disease states … Medicinal indications of cannabinoid drugs including compounds that result in enhance endocannabinoid responses (EER) have expanded markedly in recent years.”
“The wide range of indications covers … chemotherapy complications, tumor growth, addiction, pain, multiple sclerosis, glaucoma, inflammation, eating disorders, age-related neurodegenerative disorders, as well as epileptic seizures, traumatic brain injury, cerebral ischemia, and other excitotoxic insults.”
Source: “Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states,” Current Molecular Medicine, September 2006

Photo: Another Godless Goddess
Ann Druyan, president, NORML Board of Directors

​Here’s your interesting cannabis fact of the day: Ann Druyan, author, writer, television producer — and widow of astronomy legend Dr. Carl Sagan — was listed as president of the NORML Foundation Board of Directors.

Druyan was co-writer, along with her husband Sagan, of the Emmy and Peabody Award winning television series Cosmos, and served as creative director of the NASA project to design a complex message of music, images and ideas for potential alien civilizations that was placed aboard the Voyager 1 and 2 interstellar spacecraft.
She also wrote and produced the PBS Nova episode “Confession of a Weaponeer,” which covered the life of President Dwight D. Eisenhower’s science advisor, George Kistiakowsky.
1 2